Company intelligence / Profile preview

4C Medical Technologies

Maple Grove, Minnesota, United States4cmed.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 3

Overview

The AltaValve System, a novel transcatheter mitral valve replacement device with atrial-only fixation, is currently being evaluated in the pivotal ATLAS trial for patients with moderate-to-severe or severe mitral regurgitation who are unsuitable for surgery or edge-to-edge repair. The system aims to minimize complications associated with traditional TMVR devices by avoiding sub-valvular anchoring and preserving native cardiac structures. Early clinical results have led to two FDA breakthrough designations.

Therapeutic areas: Cardiovascular
Modalities: Device (Transcatheter mitral valve replacement system)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

AltaValve System

Phase 3

Indications: Mitral regurgitation

Partnerships

Boston Scientific Corporation (lead investor and strategic partner)

Beyond the preview

Go deeper on 4C Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4C Medical Technologies.

Explore the full profile